Biolibra Formulations Private Limited
About Biolibra Formulations Private Limited
Data last updated:
Biolibra Formulations Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 25 October 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2011PTC077149.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.3 Lakh. It is led by directors Chandan Sai Kumar Golagani and Rishi Ram Kumar Golagani.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Plot No.17A Health City China Gadili, Visakhapatnam, Andhra Pradesh, India – 530040.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No.17A Health City China Gadili, Visakhapatnam, Andhra Pradesh, India – 530040
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Biolibra Formulations Private Limited FY 2022 filings available
Financial Statement Summary of Biolibra Formulations Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Biolibra Formulations Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Biolibra Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Biolibra Formulations Private Limited
Biolibra Formulations has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandan Sai Kumar Golagani | Additional Director | 20 Jun 2025 | 1 Years 3 Months | Current |
| Rishi Ram Kumar Golagani | Additional Director | 20 Jun 2025 | 1 Years 3 Months | Current |
Auditor Details of Biolibra Formulations Private Limited
Biolibra Formulations Private Limited is audited by K.VENKATA REDDY & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K.VENKATA REDDY & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Biolibra Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Biolibra Formulations Private Limited
Biolibra Formulations Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Biolibra Formulations Private Limited
Employment history and EPFO contributions of people linked to Biolibra Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Biolibra Formulations Private Limited
Biolibra Formulations Private Limited has 8 board changes on record since 2011: 3 appointments and 5 cessations. The latest: Ashok Kumar Golagani ceased to be Director on 26 Jun 2025.
Credit Ratings, Litigation & Regulatory Alerts for Biolibra Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Biolibra Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Biolibra Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Biolibra Formulations Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Biolibra Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biolibra Formulations Private Limited
Biolibra Formulations is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 25 October 2011 (15+ years old) and is registered under CIN U24232AP2011PTC077149.
Biolibra Formulations has 2 current directors:
- Chandan Sai Kumar Golagani - Additional Director
- Rishi Ram Kumar Golagani - Additional Director
The CIN (Corporate Identification Number) of Biolibra Formulations is U24232AP2011PTC077149. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biolibra Formulations was incorporated on 25 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Vijayawada.
Ashok Kumar Golagani ceased to be Director on 26 Jun 2025. Golagani Aruna Jyothi ceased to be Director on 26 Jun 2025. Peethala Venkata Sudhakar ceased to be Director on 26 Jun 2025. Biolibra Formulations has 8 board changes on record in total.
The registered office of Biolibra Formulations is at Plot No.17A Health City China Gadili, Visakhapatnam, Andhra Pradesh, India – 530040.
Biolibra Formulations has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.3 Lakh.
Biolibra Formulations operates in the chemicals industry, in the chemical products segment.
No. Biolibra Formulations is not listed on any stock exchange. It is an unlisted company.
The compliance status of Biolibra Formulations is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.